Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
As of January 2021 Novartis has a market cap of $218.39 B. This makes Novartis the world's 39th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2021 | $213.27 B | -2.07% |
2020 | $217.77 B | 1.37% |
2019 | $214.83 B | 8.9% |
2018 | $197.28 B | 0.05% |
2017 | $197.18 B | 13.99% |
2016 | $172.98 B | -17.02% |
2015 | $208.46 B | -6.94% |
2014 | $224.01 B | 15.09% |
2013 | $194.64 B | 27.77% |
2012 | $152.33 B | 10.31% |
2011 | $138.09 B | 2.61% |
2010 | $134.58 B | 7.64% |
2009 | $125.03 B | 10.95% |
2008 | $112.69 B | -8.36% |
2007 | $122.98 B | -8.82% |
2006 | $134.88 B | 10.03% |
2005 | $122.58 B | -0.05% |
2004 | $122.65 B | 8.31% |
2003 | $113.24 B | 24.58% |
2002 | $90.90 B | -2.26% |
2001 | $93.00 B |